As of 2025-07-07, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.13) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -327.8%.
The range of the Relative Valuation is (0.93) - (1.31) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.1x - 10.7x | 8.9x |
| Forward P/E multiples | 7.6x - 11.3x | 9.4x |
| Fair Price | (0.93) - (1.31) | (1.13) |
| Upside | -287.7% - -365.1% | -327.8% |
| Date | P/E |